NMN
$39.99 – $109.99Price range: $39.99 through $109.99
A naturally occurring nucleotide and direct biosynthetic precursor to NAD+, extensively researched for its role in cellular energy metabolism, DNA repair, sirtuin activation, and anti-aging biology.
Molecular & analytical data
Verified chemistry and third-party reference identifiers for this compound.

Reconstitution calculator
Concentration, volume per draw, and the graduation it measures to. Open the full bench calculator with this vial loaded →
—
A U-100 insulin syringe reads 100 units per 1 mL. Figures describe the contents of a vial for laboratory handling reference only and are not dosing guidance.
Quality & verification
Every batch is characterised before release and ships with documentation.
Storage & handling
Keep the peptide stable from delivery through reconstitution.
Store at room temperature in sealed container away from moisture and light. Hygroscopic — keep tightly closed.
Nicotinamide mononucleotide (NMN, β-NMN) is a naturally occurring ribonucleotide that serves as a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for over 400 enzymatic reactions. NAD+ levels decline progressively with age, contributing to mitochondrial dysfunction, impaired DNA repair, reduced sirtuin activity, and increased metabolic disease risk — processes implicated in aging and age-related disorders. NMN is converted to NAD+ by nicotinamide mononucleotide adenylyltransferase (NMNAT) enzymes. The NAMPT-mediated salvage pathway, which produces NMN from nicotinamide, is a primary route of NAD+ biosynthesis in mammals. Animal studies have demonstrated that NMN supplementation restores NAD+ levels in aging tissues, improves insulin sensitivity, enhances mitochondrial biogenesis, activates sirtuins (SIRT1, SIRT3), and extends healthspan parameters. Human clinical trials have confirmed that NMN safely elevates blood NAD+ concentrations (optimal at 600 mg/day), with studies showing improvements in muscle insulin sensitivity in prediabetic women, reduced biological aging markers, and good tolerability at up to 900 mg/day.
Certificates of Analysis
Every batch of this peptide is tested before release. Find the batch number printed on your vial and verify or download its certificate.
| Batch # | Issued | Purity | Certificate |
|---|---|---|---|
| NHV26-B5499 COA-K8PR-MXGV-F | 04 Aug 2026 | 99.16 % HPLC | Verify at IRZC ↗ |
“Verify at IRZC” opens the laboratory’s own record for that certificate, on their site. Looking for an older batch we haven’t published? Email [email protected] with the batch number from your vial — we keep all certificates for 7 years.
The information below summarises published preclinical and clinical research for scientific reference. NHOV products are sold strictly for laboratory research use only. Nothing here is medical advice, a recommendation, or an instruction for use in humans or animals.
Mechanism of action
Converted to NAD+ by NMNAT enzymes; NAD+ activates sirtuins (SIRT1-7) for epigenetic regulation and DNA repair; NAD+ is cofactor for PARPs (DNA repair), CD38/CD157 (immune signaling), and over 400 oxidoreductases; restores mitochondrial function; activates AMPK pathway.
Primary uses / indications
Age-related NAD+ decline, metabolic syndrome, insulin resistance, cognitive aging, mitochondrial dysfunction, DNA repair support, longevity research, energy metabolism
Typical dosage (reported)
250–900 mg/day oral (clinical trials); most human studies use 250–500 mg/day; higher doses up to 2000 mg/day in some protocols
Cycle duration (reported)
Continuous supplementation or 3-month cycles; no established maximum duration
Administration route
Oral (capsule/powder), Subcutaneous injection (less common)
Side effects (reported)
Generally well tolerated. Mild GI effects (nausea, diarrhea) at high doses. Potential for excessive NAD+ metabolite production. Long-term safety data beyond 12 months limited.
Contraindications
Active cancer (NAD+ promotes cellular energy for all cells including cancer); pregnancy/breastfeeding (insufficient safety data)
Drug interactions
Potential interactions with PARP inhibitors (olaparib, niraparib) — mechanistic overlap; additive effects with resveratrol, metformin (AMPK pathway); caution with DNA-damaging chemotherapy agents
Identity
| Full name / brand names | NMN / Nicotinamide Mononucleotide / β-Nicotinamide Mononucleotide |
|---|---|
| Category | Anti-Aging & Longevity |
| Subcategory | NAD+ Precursor |
| Origin / source | Naturally occurring in all living cells; dietary sources include edamame, broccoli, avocado, tomatoes; commercial NMN is produced by enzymatic or fermentation synthesis |
| Year discovered | 1963 (structural identification); anti-aging research intensified 2013–present |
Chemistry
| Amino acid sequence | Not a peptide; nucleotide structure: nicotinamide + ribose-5-phosphate |
|---|---|
| Molecular formula | C11H15N2O8P |
| Molecular weight | 334.22 g/mol |
| CAS number | 1094-61-7 |
| PubChem CID | CID 14180 ↗ |
| Purity standard | ≥98% |
Pharmacokinetics
| Half-life | Not established in humans; NMN is rapidly metabolised to nicotinamide and incorporated into the tissue NAD+ pool rather than persisting in plasma |
|---|---|
| Bioavailability | Oral: rapidly absorbed; peak plasma in ~1-2 hours; muscle uptake via Slc12a8 transporter |
Regulatory & research status
| FDA status | Not FDA-approved as a drug. In November 2022 FDA concluded that NMN was excluded from the dietary-supplement definition under the drug-preclusion provision of the FD&C Act; in September 2025 FDA reversed that position, concluding that NMN is not excluded and may lawfully be used in dietary supplements. |
|---|---|
| Prescription required | Not required (dietary supplement in US) |
| Research status | Active human clinical trials; multiple completed phase 1/2 studies; extensive preclinical data |
| Clinical trials | NCT04823260 (NMN in healthy middle-aged adults); NCT04228640 (NMN safety and anti-aging); NCT03151239 (NMN in postmenopausal women) |
References
Yoshino J et al., "Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice", Cell Metabolism, 2011, DOI: 10.1016/j.cmet.2011.08.014; Igarashi M et al., "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels in healthy subjects", NPJ Aging and Mechanisms of Disease, 2022, DOI: 10.1038/s41514-022-00084-z; Yoshino M et al., "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women", Science, 2021, DOI: 10.1126/science.abe9985
Frequently asked questions
What is NMN?
How does NMN work?
What NMN dosage is used in research?
What is the half-life of NMN?
How should NMN be stored and reconstituted?
What purity is NHOV's NMN?
Is NMN approved for human use?
Related products
Glutathione
Antioxidant tripeptide studied in oxidative stress and detoxification research.
$39.99 – $61.99Price range: $39.99 through $61.99Epithalon
Synthetic tetrapeptide studied as a telomerase activator in longevity research.
$21.99 – $35.99Price range: $21.99 through $35.99FOXO4-DRI
Senolytic D-amino acid peptide that disrupts the FOXO4-p53 interaction.
$87.99 – $166.99Price range: $87.99 through $166.99Salidroside
Phenylpropanoid glycoside from Rhodiola rosea studied in adaptogen research.
$34.99 – $54.99Price range: $34.99 through $54.99Livagen
Synthetic bioregulatory tetrapeptide studied in liver and chromatin research.
$20.99 – $32.99Price range: $20.99 through $32.99
Actovegin
Deproteinized calf blood ultrafiltrate studied in cellular glucose uptake research.
$34.99 – $54.99Price range: $34.99 through $54.99
PNC-28
p53-derived membrane-penetrating peptide studied in HDM2-targeted cancer research.
$34.99 – $54.99Price range: $34.99 through $54.99
PNC-27
p53-derived HDM-2 binder fused to penetratin; studied in cancer-cell research.
$87.99 – $118.99Price range: $87.99 through $118.99









Reviews
Clear filtersThere are no reviews yet.